Teladoc Health (TDOC.US) saw its stock price rise over 9% on Friday, reaching $9.398 at the time of writing. Several major Wall Street firms have updated their ratings for Teladoc Health, setting target prices between $9 and $12. Notably, Bank of America analyst Allen Lutz maintained a 'Hold' rating and raised the target price from $8.50 to $9.